1 Copenhagen Trial Unit, Cochranecenteret Rigshospitalet, Rigshospitalet, The Capital Region of Denmark2 Endocrinology, Department of, Abdominal Centre, Rigshospitalet, The Capital Region of Denmark3 Department of Management Engineering4 Department of Endocrinology, Medical Center, Amager and Hvidovre Hospital, The Capital Region of Denmark5 unknown
Patients with type 2 diabetes mellitus (T2D) have an increased risk of cardiovascular disease and mortality compared to the background population. Observational studies report an association between reduced blood glucose and reduced risk of both micro- and macrovascular complications in patients with T2D. Our previous systematic review of intensive glycaemic control versus conventional glycaemic control was based on 20 randomised clinical trials that randomised 29 ,986 participants with T2D. We now report our updated review.
Cochrane Database of Systematic Reviews, 2013, Vol 11